Bactiguard Holding Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 147

Employees

  • Stock Symbol
  • BACTI B

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $3.04
  • (As of Thursday Closing)

Bactiguard Holding General Information

Description

Bactiguard Holding AB is a medical device company. It is engaged in the development of infection prevention solutions, which reduce the risk of infections and the use of antibiotics. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. Its portfolio contains urinary catheters, endotracheal tubes, central venous catheters, Hydrocyn for disinfection and wound care, as well as sutures and other wound care products. Its geographical segments are United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zeeland, and Other countries.

Contact Information

Formerly Known As
Vigilenz
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Vasagatan 11
  • 111 20 Stockholm
  • Sweden
+46 08-440
Primary Industry
Therapeutic Devices
Other Industries
Medical Supplies
Stock Exchange
STO
Corporate Office
  • Vasagatan 11
  • 111 20 Stockholm
  • Sweden
+46 08-440

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bactiguard Holding Stock Performance

As of 19-Jun-2025, Bactiguard Holding’s stock price is $3.04. Its current market cap is $106M with 35M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.04 $3.01 $2.21 - $7.31 $106M 35M 6.12K -$0.07

Bactiguard Holding Financials Summary

As of 31-Mar-2025, Bactiguard Holding has a trailing 12-month revenue of $24.1M.

In Thousands,
USD
TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 114,363 124,900 226,905 372,973
Revenue 24,122 23,041 19,192 22,348
EBITDA 2,716 2,046 (8,491) (49)
Net Income (2,313) (2,819) (13,019) (5,212)
Total Assets 57,485 59,447 66,258 77,427
Total Debt 17,101 20,643 23,324 22,882
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bactiguard Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bactiguard Holding‘s full profile, request access.

Request a free trial

Bactiguard Holding Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Bactiguard Holding AB is a medical device company. It is engaged in the development of infection prevention solutions, w
Therapeutic Devices
Stockholm, Sweden
147 As of 2025

Irvine, CA
 

Miami Lakes, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bactiguard Holding Competitors (13)

One of Bactiguard Holding’s 13 competitors is Endologix, a Corporation company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Endologix Corporation Irvine, CA
Cordis Private Equity-Backed Miami Lakes, FL
Bausch & Lomb-Iom Corporation Vimodrone, Italy
Terumo Corporation Tokyo, Japan
Alvimedica Corporation Istanbul, Turkey
You’re viewing 5 of 13 competitors. Get the full list »

Bactiguard Holding Patents

Bactiguard Holding Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4281599-A1 Silver free surface coating Pending 12-Apr-2022
AU-2023253098-A1 Silver free surface coating Pending 12-Apr-2022
CA-3208238-A1 Electro-activated super oxidized water and method of synthesizing the same Pending 12-Mar-2021
EP-4304991-A1 Electro-activated super oxidized water and method of synthesizing the same Pending 12-Mar-2021
US-20240317615-A1 Electro-activated super oxidized water and method of synthesizing the same Pending 12-Mar-2021 C02F1/4674
To view Bactiguard Holding’s complete patent history, request access »

Bactiguard Holding Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bactiguard Holding Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bactiguard Holding‘s full profile, request access.

Request a free trial

Bactiguard Holding Investments & Acquisitions (2)

Bactiguard Holding’s most recent deal was a Early Stage VC with Teint for . The deal was made on 18-Apr-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Teint 18-Apr-2023 Early Stage VC Personal Products
Vigilenz Medical Devices 28-Feb-2020 Merger/Acquisition Medical Supplies
To view Bactiguard Holding’s complete investments and acquisitions history, request access »

Bactiguard Holding ESG

Risk Overview

Risk Rating

Updated October, 15, 2024

24.13 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,673

Rank

Percentile

Healthcare

Industry

of 564

Rank

Percentile

Medical Supplies

Subindustry

of 58

Rank

Percentile

To view Bactiguard Holding’s complete esg history, request access »

Bactiguard Holding FAQs

  • When was Bactiguard Holding founded?

    Bactiguard Holding was founded in 2005.

  • Where is Bactiguard Holding headquartered?

    Bactiguard Holding is headquartered in Stockholm, Sweden.

  • What is the size of Bactiguard Holding?

    Bactiguard Holding has 147 total employees.

  • What industry is Bactiguard Holding in?

    Bactiguard Holding’s primary industry is Therapeutic Devices.

  • Is Bactiguard Holding a private or public company?

    Bactiguard Holding is a Public company.

  • What is Bactiguard Holding’s stock symbol?

    The ticker symbol for Bactiguard Holding is BACTI B.

  • What is the current stock price of Bactiguard Holding?

    As of 19-Jun-2025 the stock price of Bactiguard Holding is $3.04.

  • What is the current market cap of Bactiguard Holding?

    The current market capitalization of Bactiguard Holding is $106M.

  • What is Bactiguard Holding’s current revenue?

    The trailing twelve month revenue for Bactiguard Holding is $24.1M.

  • Who are Bactiguard Holding’s competitors?

    Endologix, Cordis, Bausch & Lomb-Iom, Terumo, and Alvimedica are some of the 13 competitors of Bactiguard Holding.

  • What is Bactiguard Holding’s annual earnings per share (EPS)?

    Bactiguard Holding’s EPS for 12 months was -$0.07.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »